News
Drugmakers Pfizer and Flynn Pharma have been fined £70 million ($84 million) by the UK Competition and Markets Authority (CMA) for overcharging the NHS for a widely-used epilepsy drug.
The strategies that the industry’s lobbyists use, or don’t deploy, matter as the Trump administration moves more decisively ...
Discover why options trading trends, robust R&D, and strong free cash flow position Pfizer Inc. for growth. Click for my ...
When blockbuster drugs lose intellectual property protections it can wipe out billions of dollars in revenue for companies ...
Limiting pharma ads would be a major win for Health and Human Services Secretary Robert F. Kennedy Jr. He has long wanted to more strictly regulate how medicines are promoted.
As a consequence of Pfizer’s innovation, the price of citric acid tumbled over the succeeding decades, with the value of the chemical falling by 5/6ths in 20 years.
As scientific breakthroughs continue to transform medicine in 2025, companies across the biotech and pharmaceutical sectors ...
Welcome to our live blog tracking the latest news and developments from the United States. Stay updated with real-time ...
Navigating 2025 Drug Pricing Policies webinar, panelists discussed the Most Favored Nation executive order, bills aimed at ...
FDA Commissioner Marty Makary suggests his agency may expedite drug reviews for manufacturers reducing U.S. prices to global ...
There's little point in pouring hundreds of millions of dollars into creating a biosimilar if PBMs will refuse to cover it.
Some results have been hidden because they may be inaccessible to you
Show inaccessible results